Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 15, 2005
Grant Date -
Oct 17, 2002
app pub date -
Feb 26, 2001
filing date -
Feb 25, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention provides polypeptides that bind cellular receptors for vascular endothelial growth factor polypeptides; polynucleotides encoding such polypeptides; compositions comprising the polypeptides and polynucleotides; and methods and uses involving the foregoing. Some polypeptides of the invention exhibit unique receptor binding profiles compared to known, naturally occurring vascular endothelial growth factors.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully